Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2T | 1.2T | 1.2T | 1.2T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 41.4B | 47.5B | 36.1B | 36.7B |
Other operating expenses | 19.6B | 26.5B | 12.4B | 13.0B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 395.8B | 370.9B | 278.1B | 367.8B |
Tax provision | 85.0B | 80.3B | 59.6B | 79.6B |
Net income | 310.8B | 290.5B | 218.4B | 288.2B |
Basic EPS | 40 | — | — | — |
Diluted EPS | 40 | — | — | — |
Basic average shares | 7.7B | — | — | — |
Diluted average shares | 7.7B | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -10M | 178M | 20M | -43M |
Preferred stock dividends | — | — | — | — |